Certara down on weak full-year outlook

Certara

10/08/2023 12:44

** Shares of drug developer Certara  CERT.O  down 14.6% to
$15.30 before the bell
    ** CERT expects FY revenue of $345 mln - $360 mln, below
analysts' expectations of $364.2 mln - Refinitiv
    ** Sees FY adjusted earnings per share of 44 cents - 48
cents vs Street expectations of 51 cents
    ** Six of 9 brokerages rate the stock "buy" or higher, and 3
"hold"; their median PT is $21 
    ** As of last close, shares up 11.5% YTD

 (Reporting by Pritam Biswas in Bengaluru)
 ((Pritam.Biswas@thomsonreuters.com))